Target Name: Insulin-like growth factor 2 mRNA binding protein
NCBI ID: P47502
Review Report on Insulin-like growth factor 2 mRNA binding protein Target / Biomarker Content of Review Report on Insulin-like growth factor 2 mRNA binding protein Target / Biomarker
Insulin-like growth factor 2 mRNA binding protein
Other Name(s): IGF2B | IMP

IGF2B: Insulin-like Growth Factor 2 and Its Role in Cell Growth and Angiogenesis

Insulin-like growth factor 2 (IGF2) is a protein that plays a crucial role in the growth and development of many organisms, including humans. IGF2 is a transmembrane protein that is characterized by its ability to bind to specific DNA sequences, particularly those of the insulin-like growth factor 2 receptor (IGF2R), which is a protein that is found on the surface of many tissues in the body.

The IGF2R is a protein that is involved in the regulation of cellular growth, cell survival, and angiogenesis (the formation of new blood vessels). It is thought to play a key role in the development and maintenance of tissues that require rapid growth and repair, such as muscle, bone, and nerve cells.

One of the proteins that is encoded by the IGF2 gene is the nonspecific subtype of IGF2, which is called IGF2B. IGF2B is a 24 kilobase (kb) protein that is highly conserved across different species, and is expressed in many tissues throughout the body, including muscle, nerve, and bone cells.

IGF2B is a protein that is characterized by its ability to bind to specific DNA sequences, particularly those of the insulin-like growth factor 2 receptor (IGF2R), which is a protein that is found on the surface of many tissues in the body.

The IGF2R is a protein that is involved in the regulation of cellular growth, cell survival, and angiogenesis. It is thought to play a key role in the development and maintenance of tissues that require rapid growth and repair, such as muscle, bone, and nerve cells.

One of the proteins that is encoded by the IGF2 gene is the nonspecific subtype of IGF2, which is called IGF2B. IGF2B is a 24 kilobase (kb) protein that is highly conserved across different species, and is expressed in many tissues throughout the body, including muscle, nerve, and bone cells.

IGF2B is able to bind to specific DNA sequences because of its unique structure. IGF2B is a transmembrane protein that consists of a single transmembrane domain and a cytoplasmic tail. The transmembrane domain is responsible for the protein's ability to bind to the IGF2R, while the cytoplasmic tail is responsible for its ability to interact with other cellular structures.

IGF2B is able to bind to the IGF2R with high affinity, which means that it is able to bind to the receptor more effectively than other proteins. This is important for the function of the protein, as the IGF2R plays a key role in the regulation of cellular growth and angiogenesis.

One of the functions of IGF2B is its ability to promote cellular growth and proliferation. IGF2B is a potent growth factor that is able to stimulate the growth of many different types of cells, including muscle, nerve, and bone cells. It is thought to do this by promoting the formation of new blood vessels, which allows cells to receive an increased supply of oxygen and nutrients.

IGF2B is also involved in the regulation of cell survival. IGF2B is able to induce the apoptosis (programmed cell death) of certain types of cells, which is a natural mechanism that helps to remove damaged or dysfunctional cells from the body. This is important for the function of many different types of tissues, including the nervous system and the immune system.

In addition to its role in cell survival and growth, IGF2B is also involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed in the body, and IGF2B is thought to play a key role in this process. IGF2B is able to stimulate the formation of new blood vessels by promoting the growth and proliferation of the endothelial cells, which are responsible for the formation of the blood vessels.

Overall, IGF2B is a protein that is highly conserved across different species and is involved in

Protein Name: Insulin-like Growth Factor 2 MRNA Binding Protein (nonspecified Subtype)

The "Insulin-like growth factor 2 mRNA binding protein Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Insulin-like growth factor 2 mRNA binding protein comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH